Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -14.98% |
| 2024 | 66.27% |
| 2023 | 19.41% |
| 2022 | -13.71% |
| 2021 | 2.94% |
| 2020 | 15.46% |
| 2019 | 37.43% |
| 2018 | 130.88% |
| 2017 | -11.83% |
| 2016 | 0.00% |